MedPath

Investigating the effect of probiotic supplementation on Brucellosis

Phase 3
Recruiting
Conditions
Brucellosis.
Brucellosis
Registration Number
IRCT20240130060856N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients with new onset Brucellosis

Exclusion Criteria

Presence of immunodeficiency in the patient
Taking immunosuppressive drugs
Presence of concomitant diseases such as tuberculosis, malignancy, liver cirrhosis and ESRD
Current pregnancy
Presence of focal, complicated or chronic forms of Brucellosis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath